ID   GFRA1_HUMAN             Reviewed;         465 AA.
AC   P56159; A8KA21; O15507; O43912;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2002, sequence version 2.
DT   28-JUN-2023, entry version 190.
DE   RecName: Full=GDNF family receptor alpha-1;
DE            Short=GDNF receptor alpha-1;
DE            Short=GDNFR-alpha-1;
DE            Short=GFR-alpha-1;
DE   AltName: Full=RET ligand 1;
DE   AltName: Full=TGF-beta-related neurotrophic factor receptor 1;
DE   Flags: Precursor;
GN   Name=GFRA1; Synonyms=GDNFRA, RETL1, TRNR1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE (ISOFORM 1).
RC   TISSUE=Substantia nigra;
RX   PubMed=8674117; DOI=10.1016/s0092-8674(00)81311-2;
RA   Jing S., Wen D., Yu Y., Holst P.L., Luo Y., Fang M., Tamir R., Antonio L.,
RA   Hu Z., Cupples R., Louis J.-C., Hu S., Altrock B.W., Fox G.M.;
RT   "GDNF-induced activation of the ret protein tyrosine kinase is mediated by
RT   GDNFR-alpha, a novel receptor for GDNF.";
RL   Cell 85:1113-1124(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Kidney;
RX   PubMed=9177201; DOI=10.1073/pnas.94.12.6238;
RA   Sanicola M., Hession C.A., Worley D.S., Carmillo P., Ehrenfels C.,
RA   Walus L., Robinson S., Jaworski G., Wei H., Tizard R., Whitty A.,
RA   Pepinsky R.B., Cate R.L.;
RT   "Glial cell line-derived neurotrophic factor-dependent RET activation can
RT   be mediated by two different cell-surface accessory proteins.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:6238-6243(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1), AND VARIANTS ASN-85
RP   AND ALA-366.
RX   PubMed=9545641; DOI=10.1006/geno.1997.5191;
RA   Angrist M., Jing S., Bolk S., Bentley K., Nallasamy S., Halushka M.,
RA   Fox G.M., Chakravarti A.;
RT   "Human GFRA1: cloning, mapping, genomic structure, and evaluation as a
RT   candidate gene for Hirschsprung disease susceptibility.";
RL   Genomics 48:354-362(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Thyroid carcinoma;
RX   PubMed=9600247; DOI=10.1007/s004390050724;
RA   Shefelbine S.E., Khorana S., Schultz P.N., Huang E., Thobe N., Hu Z.J.,
RA   Fox G.M., Jing S., Cote G.J., Gagel R.F.;
RT   "Mutational analysis of the GDNF/RET-GDNFR-alpha signaling complex in a
RT   kindred with vesicoureteral reflux.";
RL   Hum. Genet. 102:474-478(1998).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Substantia nigra;
RA   Hishiki T., Kondoh K., Ichimiya S., Nimura Y., Seki N., Ozaki T.,
RA   Sakiyama S., Takahashi H., Ohnuma N., Tanabe M., Fujimura S.,
RA   Nakagawara A.;
RT   "GDNF-induced differentiation and its enhancement by retinoic acid in
RT   primary human neuroblastomas expressing c-Ret and GDNFR-alpha.";
RL   Submitted (OCT-1997) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   SPLICE ISOFORM(S) THAT ARE POTENTIAL NMD TARGET(S).
RX   PubMed=14759258; DOI=10.1186/gb-2004-5-2-r8;
RA   Hillman R.T., Green R.E., Brenner S.E.;
RT   "An unappreciated role for RNA surveillance.";
RL   Genome Biol. 5:R8.1-R8.16(2004).
RN   [10]
RP   INTERACTION WITH RET AND SORL1.
RX   PubMed=23333276; DOI=10.1016/j.celrep.2012.12.011;
RA   Glerup S., Lume M., Olsen D., Nyengaard J.R., Vaegter C.B., Gustafsen C.,
RA   Christensen E.I., Kjolby M., Hay-Schmidt A., Bender D., Madsen P.,
RA   Saarma M., Nykjaer A., Petersen C.M.;
RT   "SorLA controls neurotrophic activity by sorting of GDNF and its receptors
RT   GFRalpha1 and RET.";
RL   Cell Rep. 3:186-199(2013).
RN   [11]
RP   INVOLVEMENT IN RHDA4, AND VARIANT RHDA4 226-ARG--SER-465 DEL.
RX   PubMed=33020172; DOI=10.1681/asn.2020040478;
RA   Arora V., Khan S., El-Hattab A.W., Dua Puri R., Rocha M.E., Merdzanic R.,
RA   Paknia O., Beetz C., Rolfs A., Bertoli-Avella A.M., Bauer P., Verma I.C.;
RT   "Biallelic Pathogenic GFRA1 Variants Cause Autosomal Recessive Bilateral
RT   Renal Agenesis.";
RL   J. Am. Soc. Nephrol. 32:223-228(2021).
RN   [12]
RP   VARIANTS ALA-366 AND ARG-371.
RX   PubMed=14566559; DOI=10.1007/s00439-003-1036-z;
RA   Sasaki A., Kanai M., Kijima K., Akaba K., Hashimoto M., Hasegawa H.,
RA   Otaki S., Koizumi T., Kusuda S., Ogawa Y., Tuchiya K., Yamamoto W.,
RA   Nakamura T., Hayasaka K.;
RT   "Molecular analysis of congenital central hypoventilation syndrome.";
RL   Hum. Genet. 114:22-26(2003).
RN   [13]
RP   VARIANT RHDA4 210-GLY--SER-465 DEL.
RX   PubMed=34737117; DOI=10.1016/j.ejmg.2021.104376;
RA   Al-Shamsi B., Al-Kasbi G., Al-Kindi A., Bruwer Z., Al-Kharusi K.,
RA   Al-Maawali A.;
RT   "Biallelic loss-of-function variants of GFRA1 cause lethal bilateral renal
RT   agenesis.";
RL   Eur. J. Med. Genet. 65:104376-104376(2022).
CC   -!- FUNCTION: Receptor for GDNF. Mediates the GDNF-induced
CC       autophosphorylation and activation of the RET receptor (By similarity).
CC       {ECO:0000250|UniProtKB:Q62997}.
CC   -!- SUBUNIT: 2 molecules of GDNFR-alpha are thought to form a complex with
CC       the disulfide-linked GDNF dimer and with 2 molecules of RET (By
CC       similarity). Interacts with RET (PubMed:23333276). Interacts with
CC       SORL1, either alone or in complex with GDNF (PubMed:23333276).
CC       Interaction between SORL1 and GFRA1 leads to GFRA1 internalization, but
CC       not degradation (PubMed:23333276). {ECO:0000250|UniProtKB:Q62997,
CC       ECO:0000269|PubMed:23333276}.
CC   -!- INTERACTION:
CC       P56159-2; Q92673: SORL1; NbExp=3; IntAct=EBI-15854635, EBI-1171329;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q62997};
CC       Lipid-anchor, GPI-anchor {ECO:0000250|UniProtKB:Q62997}. Golgi
CC       apparatus, trans-Golgi network {ECO:0000250|UniProtKB:Q62997}. Endosome
CC       {ECO:0000250|UniProtKB:Q62997}. Endosome, multivesicular body
CC       {ECO:0000250|UniProtKB:Q62997}. Note=Localizes mainly to the plasma
CC       membrane. In the presence of SORL1, shifts to vesicular structures,
CC       including trans-Golgi network, endosomes and multivesicular bodies.
CC       {ECO:0000250|UniProtKB:Q62997}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P56159-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P56159-2; Sequence=VSP_001660;
CC   -!- DISEASE: Renal hypodysplasia/aplasia 4 (RHDA4) [MIM:619887]: An
CC       autosomal recessive, severe congenital anomaly of the kidney and
CC       urinary tract characterized by bilateral renal agenesis, and severely
CC       reduced or absent amniotic fluid during pregnancy. Patients exhibit the
CC       Potter sequence, including flattened nose, ear anomalies, and receding
CC       chin. Some affected individuals have limb contractures and joint
CC       dislocations. Bilateral renal agenesis is almost invariably fatal in
CC       utero or in the perinatal period. {ECO:0000269|PubMed:33020172,
CC       ECO:0000269|PubMed:34737117}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: [Isoform 2]: May be produced at very low levels due to a
CC       premature stop codon in the mRNA, leading to nonsense-mediated mRNA
CC       decay. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the GDNFR family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U97144; AAC51646.1; -; mRNA.
DR   EMBL; AF038420; AAC39693.1; -; Genomic_DNA.
DR   EMBL; AF038411; AAC39693.1; JOINED; Genomic_DNA.
DR   EMBL; AF038412; AAC39693.1; JOINED; Genomic_DNA.
DR   EMBL; AF038413; AAC39693.1; JOINED; Genomic_DNA.
DR   EMBL; AF038414; AAC39693.1; JOINED; Genomic_DNA.
DR   EMBL; AF038415; AAC39693.1; JOINED; Genomic_DNA.
DR   EMBL; AF038416; AAC39693.1; JOINED; Genomic_DNA.
DR   EMBL; AF038417; AAC39693.1; JOINED; Genomic_DNA.
DR   EMBL; AF038418; AAC39693.1; JOINED; Genomic_DNA.
DR   EMBL; AF038419; AAC39693.1; JOINED; Genomic_DNA.
DR   EMBL; AF038421; AAC39692.1; -; mRNA.
DR   EMBL; AF042080; AAB97371.1; -; mRNA.
DR   EMBL; AF058999; AAC14431.1; -; Genomic_DNA.
DR   EMBL; AF058990; AAC14431.1; JOINED; Genomic_DNA.
DR   EMBL; AF058991; AAC14431.1; JOINED; Genomic_DNA.
DR   EMBL; AF058992; AAC14431.1; JOINED; Genomic_DNA.
DR   EMBL; AF058993; AAC14431.1; JOINED; Genomic_DNA.
DR   EMBL; AF058994; AAC14431.1; JOINED; Genomic_DNA.
DR   EMBL; AF058995; AAC14431.1; JOINED; Genomic_DNA.
DR   EMBL; AF058996; AAC14431.1; JOINED; Genomic_DNA.
DR   EMBL; AF058997; AAC14431.1; JOINED; Genomic_DNA.
DR   EMBL; AF058998; AAC14431.1; JOINED; Genomic_DNA.
DR   EMBL; U95847; AAB71811.1; -; mRNA.
DR   EMBL; AK292886; BAF85575.1; -; mRNA.
DR   EMBL; CH471066; EAW49458.1; -; Genomic_DNA.
DR   EMBL; BC014962; AAH14962.1; -; mRNA.
DR   CCDS; CCDS44481.1; -. [P56159-1]
DR   CCDS; CCDS7593.1; -. [P56159-2]
DR   RefSeq; NP_001138925.1; NM_001145453.2. [P56159-2]
DR   RefSeq; NP_001335025.1; NM_001348096.1. [P56159-2]
DR   RefSeq; NP_001335026.1; NM_001348097.1.
DR   RefSeq; NP_001335027.1; NM_001348098.1. [P56159-1]
DR   RefSeq; NP_005255.1; NM_005264.5. [P56159-1]
DR   RefSeq; NP_665736.1; NM_145793.4. [P56159-2]
DR   RefSeq; XP_011537936.1; XM_011539634.1.
DR   PDB; 6Q2N; EM; 4.40 A; C/D=25-426.
DR   PDBsum; 6Q2N; -.
DR   AlphaFoldDB; P56159; -.
DR   SMR; P56159; -.
DR   BioGRID; 108942; 45.
DR   DIP; DIP-59052N; -.
DR   IntAct; P56159; 4.
DR   STRING; 9606.ENSP00000347591; -.
DR   ChEMBL; CHEMBL3833481; -.
DR   GuidetoPHARMACOLOGY; 1743; -.
DR   GlyConnect; 1265; 9 N-Linked glycans (1 site).
DR   GlyCosmos; P56159; 3 sites, 8 glycans.
DR   GlyGen; P56159; 6 sites, 8 N-linked glycans (1 site), 2 O-linked glycans (3 sites).
DR   iPTMnet; P56159; -.
DR   PhosphoSitePlus; P56159; -.
DR   BioMuta; GFRA1; -.
DR   DMDM; 20141405; -.
DR   jPOST; P56159; -.
DR   MassIVE; P56159; -.
DR   MaxQB; P56159; -.
DR   PaxDb; P56159; -.
DR   PeptideAtlas; P56159; -.
DR   ProteomicsDB; 56888; -. [P56159-1]
DR   ProteomicsDB; 56889; -. [P56159-2]
DR   Antibodypedia; 18697; 488 antibodies from 40 providers.
DR   DNASU; 2674; -.
DR   Ensembl; ENST00000355422.11; ENSP00000347591.6; ENSG00000151892.16. [P56159-1]
DR   Ensembl; ENST00000369234.5; ENSP00000358237.4; ENSG00000151892.16. [P56159-1]
DR   Ensembl; ENST00000369236.5; ENSP00000358239.1; ENSG00000151892.16. [P56159-2]
DR   Ensembl; ENST00000439649.8; ENSP00000393725.3; ENSG00000151892.16. [P56159-2]
DR   Ensembl; ENST00000682743.1; ENSP00000507970.1; ENSG00000151892.16. [P56159-2]
DR   Ensembl; ENST00000684105.1; ENSP00000506818.1; ENSG00000151892.16. [P56159-2]
DR   GeneID; 2674; -.
DR   KEGG; hsa:2674; -.
DR   MANE-Select; ENST00000355422.11; ENSP00000347591.6; NM_005264.8; NP_005255.1.
DR   UCSC; uc001lci.4; human. [P56159-1]
DR   AGR; HGNC:4243; -.
DR   CTD; 2674; -.
DR   DisGeNET; 2674; -.
DR   GeneCards; GFRA1; -.
DR   HGNC; HGNC:4243; GFRA1.
DR   HPA; ENSG00000151892; Low tissue specificity.
DR   MalaCards; GFRA1; -.
DR   MIM; 601496; gene.
DR   MIM; 619887; phenotype.
DR   neXtProt; NX_P56159; -.
DR   OpenTargets; ENSG00000151892; -.
DR   Orphanet; 1848; Renal agenesis, bilateral.
DR   PharmGKB; PA28653; -.
DR   VEuPathDB; HostDB:ENSG00000151892; -.
DR   eggNOG; ENOG502QQA2; Eukaryota.
DR   GeneTree; ENSGT00940000155560; -.
DR   HOGENOM; CLU_040179_1_1_1; -.
DR   InParanoid; P56159; -.
DR   OMA; FFQDNIC; -.
DR   OrthoDB; 3899332at2759; -.
DR   PhylomeDB; P56159; -.
DR   TreeFam; TF331647; -.
DR   PathwayCommons; P56159; -.
DR   Reactome; R-HSA-419037; NCAM1 interactions.
DR   Reactome; R-HSA-5673001; RAF/MAP kinase cascade.
DR   Reactome; R-HSA-8853659; RET signaling.
DR   SignaLink; P56159; -.
DR   SIGNOR; P56159; -.
DR   BioGRID-ORCS; 2674; 13 hits in 1150 CRISPR screens.
DR   ChiTaRS; GFRA1; human.
DR   GeneWiki; GDNF_family_receptor_alpha_1; -.
DR   GenomeRNAi; 2674; -.
DR   Pharos; P56159; Tbio.
DR   PRO; PR:P56159; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   RNAct; P56159; protein.
DR   Bgee; ENSG00000151892; Expressed in endometrium epithelium and 153 other tissues.
DR   Genevisible; P56159; HS.
DR   GO; GO:0030424; C:axon; IEA:Ensembl.
DR   GO; GO:0009897; C:external side of plasma membrane; IBA:GO_Central.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0019898; C:extrinsic component of membrane; TAS:ProtInc.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005771; C:multivesicular body; IEA:UniProtKB-SubCell.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0098797; C:plasma membrane protein complex; IEA:Ensembl.
DR   GO; GO:0043235; C:receptor complex; IBA:GO_Central.
DR   GO; GO:0016167; F:glial cell-derived neurotrophic factor receptor activity; TAS:ProtInc.
DR   GO; GO:0005178; F:integrin binding; IEA:Ensembl.
DR   GO; GO:0005030; F:neurotrophin receptor activity; IEA:Ensembl.
DR   GO; GO:0038023; F:signaling receptor activity; IBA:GO_Central.
DR   GO; GO:0005102; F:signaling receptor binding; TAS:ProtInc.
DR   GO; GO:0007568; P:aging; IEA:Ensembl.
DR   GO; GO:0016477; P:cell migration; IEA:Ensembl.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; NAS:UniProtKB.
DR   GO; GO:0001822; P:kidney development; IEA:Ensembl.
DR   GO; GO:0008584; P:male gonad development; IEA:Ensembl.
DR   GO; GO:0007399; P:nervous system development; IBA:GO_Central.
DR   GO; GO:0031175; P:neuron projection development; IEA:Ensembl.
DR   GO; GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IEA:Ensembl.
DR   Gene3D; 1.10.220.110; GDNF binding domain; 1.
DR   InterPro; IPR016017; GDNF/GAS1.
DR   InterPro; IPR037193; GDNF_alpha.
DR   InterPro; IPR003438; GDNF_rcpt.
DR   InterPro; IPR003503; GDNF_rcpt_A1.
DR   InterPro; IPR017372; Glial_neurotroph_fac_rcpt_a1/2.
DR   PANTHER; PTHR10269:SF3; GDNF FAMILY RECEPTOR ALPHA-1; 1.
DR   PANTHER; PTHR10269; GDNF RECEPTOR ALPHA; 1.
DR   Pfam; PF02351; GDNF; 3.
DR   PIRSF; PIRSF038071; GDNF_family_receptor_alpha; 1.
DR   PRINTS; PR01317; GDNFRALPHA1.
DR   PRINTS; PR01316; GDNFRECEPTOR.
DR   SMART; SM00907; GDNF; 3.
DR   SUPFAM; SSF110035; GDNF receptor-like; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Disease variant;
KW   Disulfide bond; Endosome; Glycoprotein; Golgi apparatus; GPI-anchor;
KW   Lipoprotein; Membrane; Receptor; Reference proteome; Repeat; Signal.
FT   SIGNAL          1..24
FT                   /evidence="ECO:0000255"
FT   CHAIN           25..429
FT                   /note="GDNF family receptor alpha-1"
FT                   /id="PRO_0000010777"
FT   PROPEP          430..465
FT                   /note="Removed in mature form"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_0000010778"
FT   REPEAT          25..113
FT                   /note="1"
FT   REPEAT          150..238
FT                   /note="2"
FT   REPEAT          239..342
FT                   /note="3"
FT   LIPID           429
FT                   /note="GPI-anchor amidated serine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        59
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        347
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        406
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        29..87
FT                   /evidence="ECO:0000250"
FT   DISULFID        36..42
FT                   /evidence="ECO:0000250"
FT   DISULFID        52..72
FT                   /evidence="ECO:0000250"
FT   DISULFID        89..99
FT                   /evidence="ECO:0000250"
FT   DISULFID        154..214
FT                   /evidence="ECO:0000250"
FT   DISULFID        161..167
FT                   /evidence="ECO:0000250"
FT   DISULFID        178..192
FT                   /evidence="ECO:0000250"
FT   DISULFID        187..233
FT                   /evidence="ECO:0000250"
FT   DISULFID        216..221
FT                   /evidence="ECO:0000250"
FT   DISULFID        243..313
FT                   /evidence="ECO:0000250"
FT   DISULFID        250..256
FT                   /evidence="ECO:0000250"
FT   DISULFID        267..285
FT                   /evidence="ECO:0000250"
FT   DISULFID        277..337
FT                   /evidence="ECO:0000250"
FT   DISULFID        315..325
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         140..144
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:9177201,
FT                   ECO:0000303|Ref.5"
FT                   /id="VSP_001660"
FT   VARIANT         85
FT                   /note="Y -> N (in dbSNP:rs8192662)"
FT                   /evidence="ECO:0000269|PubMed:9545641"
FT                   /id="VAR_012488"
FT   VARIANT         210..465
FT                   /note="Missing (in RHDA4)"
FT                   /evidence="ECO:0000269|PubMed:34737117"
FT                   /id="VAR_087454"
FT   VARIANT         226..465
FT                   /note="Missing (in RHDA4)"
FT                   /evidence="ECO:0000269|PubMed:33020172"
FT                   /id="VAR_087455"
FT   VARIANT         366
FT                   /note="T -> A (in dbSNP:rs2072276)"
FT                   /evidence="ECO:0000269|PubMed:14566559,
FT                   ECO:0000269|PubMed:9545641"
FT                   /id="VAR_012489"
FT   VARIANT         371
FT                   /note="L -> R (may be involved in congenital central
FT                   hypoventilation syndrome; dbSNP:rs924541616)"
FT                   /evidence="ECO:0000269|PubMed:14566559"
FT                   /id="VAR_018261"
FT   CONFLICT        245
FT                   /note="Missing (in Ref. 1; no nucleotide entry)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        358
FT                   /note="F -> P (in Ref. 1; no nucleotide entry)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   465 AA;  51456 MW;  91A550D06A6777BD CRC64;
     MFLATLYFAL PLLDLLLSAE VSGGDRLDCV KASDQCLKEQ SCSTKYRTLR QCVAGKETNF
     SLASGLEAKD ECRSAMEALK QKSLYNCRCK RGMKKEKNCL RIYWSMYQSL QGNDLLEDSP
     YEPVNSRLSD IFRVVPFISD VFQQVEHIPK GNNCLDAAKA CNLDDICKKY RSAYITPCTT
     SVSNDVCNRR KCHKALRQFF DKVPAKHSYG MLFCSCRDIA CTERRRQTIV PVCSYEEREK
     PNCLNLQDSC KTNYICRSRL ADFFTNCQPE SRSVSSCLKE NYADCLLAYS GLIGTVMTPN
     YIDSSSLSVA PWCDCSNSGN DLEECLKFLN FFKDNTCLKN AIQAFGNGSD VTVWQPAFPV
     QTTTATTTTA LRVKNKPLGP AGSENEIPTH VLPPCANLQA QKLKSNVSGN THLCISNGNY
     EKEGLGASSH ITTKSMAAPP SCGLSPLLVL VVTALSTLLS LTETS
//
